AI integration in diagnostic medicine for early detection of cancer and neurodegenerative diseases

Artificial intelligence is increasingly utilized to identify early biomarkers for cancer and Parkinson's disease, potentially enabling intervention years before clinical symptom onset. While the technology's diagnostic efficacy is growing, the long-term clinical outcomes and integration into standard healthcare protocols remain subject to ongoing validation.